← All products

Peptides · peptide

Semax

Met-Glu-His-Phe-Pro-Gly-Pro, an ACTH(4-7) analog

Also sold as: Semaks · ACTH(4-7) analog · N-Acetyl Semax · Semax amidate

A heptapeptide nootropic registered as a medicine in Russia but not approved by the FDA, sold elsewhere as a research chemical in several distinct chemical forms.

Status varies by jurisdictionResearch use only

What the evidence says

Graded on the compound profile, not restated here.

Semax

A heptapeptide nootropic derived from ACTH(4-10), registered as a medicine in Russia but not approved by the FDA or in most of the world. Human data exists but sits almost entirely in Russian-language literature that is hard to independently verify.

  • CPreliminaryCognitive / nootropic effectsHuman data exists but is mostly Russian and hard to verify independently.
  • CPreliminaryIschemic stroke / neuroprotection recoveryUsed clinically in Russia; evidence base is regional and not independently replicated.
  • DPreclinicalBDNF / neurotrophic mechanismPreclinical mechanism, mostly in rodents.
  • UUnknownLong-term human safetyPoorly characterized outside Russian clinical use; no independent long-term data.
Full Semax evidence profile →

Semax has a genuine research history — the compound profile grades its cognitive and stroke-recovery evidence at C, which is higher than most of this catalog. It is also registered as a medicine in Russia.

Neither fact tells you anything about the vial in front of you.

Registration applies to a product, not a molecule

This is the misreading that does the most work in Semax marketing. A pharmaceutical registration covers a specific manufacturer’s product, made to a specific standard, with documented identity and sterility. A research-chemical vial bought online is not that product, and the registration does not extend to it.

The same logic applies to the clinical literature: it studied the registered preparation.

Which Semax are you buying?

Three forms circulate under overlapping names — plain Semax, N-Acetyl Semax, and N-Acetyl Semax Amidate. The modifications change the molecule and are claimed to change its duration, which means they are also claimed to justify a price difference.

A certificate that names the trade form but not the sequence and modification has not confirmed which one is in the vial. Ask for both, and for the mass-spec result that distinguishes them — the acetyl and amidate groups are exactly the detail a substituted product would omit.

Most of the human work sits in Russian-language literature that is hard to verify independently, which is worth holding alongside the C grade.

Before you buy

  • Establish which form you are buying. Semax, N-Acetyl Semax, and N-Acetyl Semax Amidate are different molecules sold under overlapping names.
  • Require the sequence and modification stated explicitly on the COA, not just the trade name.
  • Confirm mass-spec identity — the acetyl and amidate modifications change the mass and are the cheapest thing to omit.
  • Treat Russian pharmaceutical registration as irrelevant to what a grey-market vial contains. Registration applies to a specific manufacturer's product.

What is sold

Forms
Lyophilized vial · Nasal spray solution
Typical price
$36.99–$74.99 depending on strength Indicative only. Not a live price.
Storage
Supplied lyophilized or as a prepared nasal solution. Prepared solutions carry the shorter shelf life and depend on the preservative used.

Last reviewed 2026-08-24.